A Randomized, Double-Blinded, Placebo-Controlled Trial of Simvastatin to Prevent Recurrent Pancreatitis

Pancreas. 2022 Jan 1;51(1):e10-e12. doi: 10.1097/MPA.0000000000001955.
No abstract available

Publication types

  • Letter
  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, N.I.H., Extramural

MeSH terms

  • Double-Blind Method
  • Female
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
  • Male
  • Pancreatitis, Chronic / prevention & control*
  • Placebo Effect
  • Recurrence
  • Secondary Prevention*
  • Simvastatin / therapeutic use*

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Simvastatin